Literature DB >> 16202181

Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia.

Chihiro Kakiuchi1, Mizuho Ishiwata, Mizue Kametani, Cheryl Nelson, Kazuya Iwamoto, Tadafumi Kato.   

Abstract

Several clinical, genetic and neuroimaging studies implicate mitochondrial dysfunction in the pathophysiology of bipolar disorder and schizophrenia. It has been reported that a mitochondrial DNA (mtDNA) deletion of 4,977 bp, known as the 'common deletion', is associated with both mental illnesses. A lack of normal age-related accumulation of this deletion in schizophrenia and increased occurrence of the common deletion in bipolar disorder have been reported. However, even in the affected bipolar samples, the levels of common deletion were relatively small, indicating that the common deletion did not play a pathophysiological role in respiratory function. We hypothesized that accumulation of multiple mtDNA deletions, rather than the common deletion alone, is involved in the pathophysiology of these two major mental disorders. To test this hypothesis, we assessed mtDNA deletion(s) by comparing the copy number of two regions in mtDNA -- ND1 and ND4 -- using real-time quantitative PCR in the frontal cortex of 84 subjects (30 control, 27 with bipolar disorder, and 27 with schizophrenia). We also assessed the relative amount of mtDNA vs. nuclear DNA and the expression level of DNA polymerase gamma (POLG), which is involved in replicating mtDNA. We observed no association between mtDNA deletions and the two major mental disorders in the frontal cortex, which did not support our hypothesis. We did, however, make the following observations, although they were not significant after Bonferroni correction: (1) the ratio of mtDNA to nuclear DNA was significantly higher in female patients with schizophrenia than in control females ( p =0.040) and (2) in bipolar disorder, the relative amount of mtDNA decreased with age ( p =0.016). furthermore, POLG expression was significantly up-regulated in bipolar disorder ( p =0.036). Our results suggest that abnormalities in the system maintaining replication of mtdna may underlie bipolar disorder and schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202181     DOI: 10.1017/S1461145705005213

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  30 in total

1.  Mitochondrial Impairment in Well-Suppressed Children with Perinatal HIV-Infection on Antiretroviral Therapy.

Authors:  Jing Shen; Afaaf Liberty; Stephanie Shiau; Renate Strehlau; Sheila Pierson; Faeezah Patel; LiQun Wang; Megan Burke; Avy Violari; Ashraf Coovadia; Elaine J Abrams; Stephen Arpadi; Marc Foca; Louise Kuhn
Journal:  AIDS Res Hum Retroviruses       Date:  2019-07-15       Impact factor: 2.205

2.  The somatic common deletion in mitochondrial DNA is decreased in schizophrenia.

Authors:  Firoza Mamdani; Brandi Rollins; Ling Morgan; P Adolfo Sequeira; Marquis P Vawter
Journal:  Schizophr Res       Date:  2014-09-28       Impact factor: 4.939

3.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

4.  Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder.

Authors:  S Sabunciyan; E Kirches; G Krause; B Bogerts; C Mawrin; I C Llenos; S Weis
Journal:  J Neural Transm (Vienna)       Date:  2007-01-03       Impact factor: 3.575

Review 5.  Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications.

Authors:  Tadafumi Kato
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Alterations of Mitochondrial DNA Copy Number and Telomere Length With Early Adversity and Psychopathology.

Authors:  Audrey R Tyrka; Stephanie H Parade; Lawrence H Price; Hung-Teh Kao; Barbara Porton; Noah S Philip; Emma S Welch; Linda L Carpenter
Journal:  Biol Psychiatry       Date:  2015-01-15       Impact factor: 13.382

7.  Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence.

Authors:  Brandi L Rollins; Ling Morgan; Brooke E Hjelm; Adolfo Sequeira; Alan F Schatzberg; Jack D Barchas; Francis S Lee; Rick M Myers; Stanley J Watson; Huda Akil; Steven G Potkin; William E Bunney; Marquis P Vawter
Journal:  Mol Neuropsychiatry       Date:  2017-11-30

8.  A Genome-Wide Search for Bipolar Disorder Risk Loci Modified by Mitochondrial Genome Variation.

Authors:  Euijung Ryu; Malik Nassan; Gregory D Jenkins; Sebastian M Armasu; Ana Andreazza; Susan L McElroy; Marquis P Vawter; Mark A Frye; Joanna M Biernacka
Journal:  Mol Neuropsychiatry       Date:  2017-10-28

Review 9.  DNA Damage in Major Psychiatric Diseases.

Authors:  Muhammad Ummear Raza; Turan Tufan; Yan Wang; Christopher Hill; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2016-04-28       Impact factor: 3.911

Review 10.  Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder.

Authors:  Rafael T de Sousa; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Expert Opin Ther Targets       Date:  2014-07-24       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.